Dr
Fiona
Edwards

European Patent Attorney

Glasgow Office

Chemistry

Telephone. +44(0) 141 229 5800
Email. [email protected]

Experience

Fiona has a wide range of practical experience and specialises in patents in the chemical, pharmaceutical and healthcare fields. Fiona's experience includes provision of advice and drafting patent applications in relation to pharmaceuticals, colour chemicals, pigments, polymer chemistry, personal care products, chemical synthesis and processes as well as medical devices.

Fiona's specialist areas of patent practice are predominantly within the chemical, pharmaceutical, medical devices and healthcare spheres, and she also brings her wide-ranging practical experience to bear for clients with innovative technologies in other areas including chemical engineering, physics as well as in relation to registered designs for new products.

With extensive practical patent experience gained from 24 years in practice both at HGF and previously in industry, Fiona brings a customer-focussed approach to her work. Her practice is predominantly related to the chemical, pharmaceutical and healthcare fields and specifically includes pharmaceuticals, colour chemicals and pigments, polymer chemistry, chemical synthesis and processes, as well as formulations for personal care products, and also medical devices. Her clients range from UK start-up companies and SMEs, to world leading universities and multi-national organisations with substantial patent portfolios.

Prior to joining HGF, Fiona worked in industry for 18 years, initially in research before qualifying as a patent attorney. Whilst working in the patent department of a global pharmaceutical company she was responsible for managing the patent portfolios for both marketplace pharmaceutical products and a range of high-value development drug compounds.

Qualifications

Patent Attorney

Europe


BSC

Chemsitry

PHD

Chemistry

CSR

Fiona has been a judge on a range of innovation awards and mentored a range of trainee attorneys and support staff.

Related News

From Theoretical Proposals to Commercial Reality: The Rise of Innovation and Patent Filings in Quantum Computing

The possibility of quantum computing was first seriously proposed in the early 1980s and is widely regarded as having enormous potential to deliver a step change in the complexity of …

Read article
Event - 3rd February 2023

The European Patent Office are running an inspiring collaborative art competition for children

To celebrate the 50th anniversary of the signing of the European Patent Convention, The European Patent Office (EPO) is running a collaborative art competition for primary schools on the topic …

Event details
Event - 8th-9th February 2023

5th Annual Microbiome & Probiotic Conference 2023

The 5th Annual MarketsandMarkets Next Gen Microbiome and Probiotics Conference will take place in San Diego on the 8th-9th of February. This conference will enable you to learn about microbial …

Event details
Event - 17th January 2023

CIPA Webinar: Enhancing Diversity in the Patent Profession How Can I Help

CIPA hosted a webinar to discuss ‘Enhancing diversity in the patent profession.’ Date Tuesday 17 January, 2023 Time 12.30pm – 1.30pm (GMT) Equity, diversity and inclusion has been in the …

Event details

LiDAR: A Significant Support Technology at CES

When visiting CES’ one thing that struck me was the number of companies demonstrating LiDAR technology. LiDAR has been around since the 1960s and was originally developed for aerospace use, …

Read article

Healthcare and Climate Change

Can we find a balance between intellectual property rights and public health needs when tackling the climate crisis? “The world faces a critical juncture. A health-centred, aligned response to the …

Read article

Navigating the CRISPR IP confusion

It is just over 10 years since the Science publication of Jinek et al. showed for the first time that DNA cleavage could be achieved in vitro with a Cas9 …

Read article

CRISPR Edited T cells win the TvT Battle

T-cells which have been modified using CRISPR base editing technology have been successfully used to treat T-cell acute lymphoblastic leukaemia for the first time {1}. A 13 year old patient …

Read article

Let's talk

If you would like to discuss how HGF could help you, contact one of our IP specialists.